COMP <GO>
MDLZ vs ADM // EV/EBITDA & P/E VALUATION
Mondelez International Inc. (NASDAQ) VS. Archer-Daniels-Midland Company (NYSE) • 15-METRIC TALLY: MDLZ 10
— ADM 3
▲ EV/EBITDA & P/E VALUATION LEADER: ADM
LAST: $64.94 (+3.85%) • MKT CAP: $79.81B
valuation
19.5x
LAST: $76.91 (+0.93%) • MKT CAP: $36.73B
valuation
17.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MDLZ VS. ADM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MDLZ | ADM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.40% | 20.20% | +8.20 | MDLZ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.70% | 3.20% | +4.50 | MDLZ | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 19.5x | 17.8x | +1.70 | ADM | /valuation <GO> |
| Free Cash Flow Yield | 4.05% | 11.45% | -7.40 | ADM | /fcf-yield <GO> |
| Operating Margin | 9.20% | 5.30% | +3.90 | MDLZ | /operating-margins <GO> |
| Net Profit Margin | 6.40% | 4.30% | +2.10 | MDLZ | /net-margins <GO> |
| Revenue Growth (YoY) | 5.80% | 2.40% | +3.40 | MDLZ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.12% | 2.69% | +0.43 | MDLZ | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.32 | 2.19 | +0.13 | MDLZ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.8 | 34.3 | +16.50 | MDLZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.96 | -0.03 | ADM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.3x | 31.7x | -1.40 | MDLZ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $79.81B | $36.73B | $43.08B | MDLZ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MDLZ REV | ADM REV | MDLZ GROSS % | ADM GROSS % | MDLZ FCF | ADM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $38.54B | $24.96B | 28.4% | 20.2% | $3.23B | $4.20B |
| FY 2024 | $36.44B | $24.37B | 39.1% | 23.7% | $3.52B | $1.23B |
| FY 2023 | $36.02B | $25.69B | — | — | $3.09B | $3.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MDLZ // BETA 0.93
ADM // BETA 0.96